These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1603705)

  • 1. Pediatric intramuscular injections: do you know the procedure and complications?
    Losek JD; Gyuro J
    Pediatr Emerg Care; 1992 Apr; 8(2):79-81. PubMed ID: 1603705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone.
    Baskin MN; O'Rourke EJ; Fleisher GR
    J Pediatr; 1992 Jan; 120(1):22-7. PubMed ID: 1731019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious bacterial infections in children. When can outpatient treatment be used?
    Gordon P
    Postgrad Med; 1991 Jul; 90(1):87-90. PubMed ID: 2062765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily ceftriaxone in the outpatient treatment of paediatric infections.
    Bradley JS
    Chemotherapy; 1991; 37 Suppl 3():3-6. PubMed ID: 1884651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dorsogluteal intramuscular injection depth needed to reach muscle tissue according to body mass index and gender: A systematic review.
    Strohfus P; Palma S; Wallace CT
    J Clin Nurs; 2022 Oct; 31(19-20):2943-2958. PubMed ID: 34791732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otolaryngology and infectious disease team approach for outpatient management of serious pediatric infections requiring parenteral antibiotic therapy.
    Einhorn M; Fliss DM; Leiberman A; Dagan R
    Int J Pediatr Otorhinolaryngol; 1992 Nov; 24(3):245-51. PubMed ID: 1399313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes.
    Tubiana-Rufi N; Belarbi N; Du Pasquier-Fediaevsky L; Polak M; Kakou B; Leridon L; Hassan M; Czernichow P
    Diabetes Care; 1999 Oct; 22(10):1621-5. PubMed ID: 10526725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.
    Taddio A; Ilersich AL; Ipp M; Kikuta A; Shah V;
    Clin Ther; 2009; 31 Suppl 2():S48-76. PubMed ID: 19781436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular injection practices of pediatric nurses: site selection.
    Beecroft PC; Redick SA
    Nurse Educ; 1990; 15(4):23-8. PubMed ID: 2377326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children.
    Leibovitz E; Tabachnik E; Fliedel O; Steinberg S; Miskin A; Askenazi A; Barak Y
    Clin Pediatr (Phila); 1990 Nov; 29(11):634-9. PubMed ID: 2265514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sciatic paralysis after a buttock intramuscular injection in children: an ongoing risk factor].
    Mayer M; Romain O
    Arch Pediatr; 2001 Mar; 8(3):321-3. PubMed ID: 11270260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible complications of intramuscular injections on the pediatric unit.
    Beecroft PC; Redick S
    Pediatr Nurs; 1989; 15(4):333-6, 376. PubMed ID: 2685732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful outpatient management of pelvic actinomycosis by ceftriaxone: a report of three cases.
    Onal ED; Altinbas A; Onal IK; Ascioglu S; Akpinar MG; Himmetoglu C; Sardan YC
    Braz J Infect Dis; 2009 Oct; 13(5):391-3. PubMed ID: 20428643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites.
    Larkin TA; Ashcroft E; Hickey BA; Elgellaie A
    J Clin Nurs; 2018 Jan; 27(1-2):e242-e250. PubMed ID: 28618093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drawing up and administering intramuscular injections: a review of the literature.
    Rodger MA; King L
    J Adv Nurs; 2000 Mar; 31(3):574-82. PubMed ID: 10718876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of intramuscular injection of concentrated certriaxone in children.
    Bradley JS; Compogiannis LS; Murray WE; Acosta MA; Tsu GL
    Clin Pharm; 1992 Nov; 11(11):961-4. PubMed ID: 1464221
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasibility of short-term outpatient intravenous antibiotic therapy for the management of infectious conditions in pediatric patients.
    Reid S; Bonadio W
    Am J Emerg Med; 2006 Nov; 24(7):839-42. PubMed ID: 17098108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.